Indications and Outcomes of Uterine Artery Embolization in Patients with Uterine Leiomyomas
Clinical outcomes of UAE in patients with uterine leiomyomas ().
Improvement of symptoms and/or reduction in the leiomyoma size
Reduction in the leiomyoma volume at 6 months after UAE ()
67.9 ± 16.3% ()
Removal of submucosal leiomyoma
Improvement of anemia
Hemoglobin value at 2 months after UAE (g/dL)
8.5 ± 3.0 →11.5 ± 1.5 ()
Abdominal pain, nausea, and fever
all the patients, short term
Elevated liver enzymes
Mean ± standard deviation.
We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at firstname.lastname@example.org to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.